Skip to content
10-Q

Quarterly Report

ICOSAVAX, INC.

0000950170-23-020615

← back to feed
Filed
May 10, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 3, 2023 41.43M sh
Shares Diluted Q1 2023 · Mar 31, 2023 41.26M sh
Shares Diluted Q1 2023 · Mar 31, 2022 39.4M sh
Capex Q1 2023 · Mar 31, 2023 $1.57M
Capex Q1 2023 · Mar 31, 2022 $1.12M
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$21.65M
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$17.46M
Short Term Investments Q1 2023 · Mar 31, 2023 $147.25M
Short Term Investments Q1 2023 · Dec 31, 2022 $159.46M
Cash And Equivalents Q1 2023 · Mar 31, 2023 $50.4M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $59.91M
Cash And Equivalents Q1 2023 · Mar 31, 2022 $262.42M
Cash And Equivalents Q1 2023 · Dec 31, 2021 $280.72M
Stockholders Equity Q1 2023 · Mar 31, 2023 $200.08M
Stockholders Equity Q1 2023 · Dec 31, 2022 $218.16M
Stockholders Equity Q1 2023 · Mar 31, 2022 $259.54M
Stockholders Equity Q1 2023 · Dec 31, 2021 $278.22M
Current Liabilities Q1 2023 · Mar 31, 2023 $12.9M
Current Liabilities Q1 2023 · Dec 31, 2022 $13.79M
Total Liabilities Q1 2023 · Mar 31, 2023 $19.59M
Total Liabilities Q1 2023 · Dec 31, 2022 $20.52M
Current Assets Q1 2023 · Mar 31, 2023 $202.17M
Current Assets Q1 2023 · Dec 31, 2022 $223.91M
Total Assets Q1 2023 · Mar 31, 2023 $219.67M
Total Assets Q1 2023 · Dec 31, 2022 $238.68M
Eps Diluted Q1 2023 · Mar 31, 2023 −$0.60
Eps Diluted Q1 2023 · Mar 31, 2022 −$0.60
Eps Basic Q1 2023 · Mar 31, 2023 −$0.60
Eps Basic Q1 2023 · Mar 31, 2022 −$0.60
Sga Expense Q1 2023 · Mar 31, 2023 $9.17M
Sga Expense Q1 2023 · Mar 31, 2022 $6.32M
Rd Expense Q1 2023 · Mar 31, 2023 $17.36M
Rd Expense Q1 2023 · Mar 31, 2022 $17.91M
Net Income Q1 2023 · Mar 31, 2023 −$24.56M
Net Income Q1 2023 · Mar 31, 2022 −$23.53M
Operating Income Q1 2023 · Mar 31, 2023 −$26.52M
Operating Income Q1 2023 · Mar 31, 2022 −$23.65M